Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis

Saad Alkhowaiter; Maha M. Al Rasheed; Nuha Alammar; Ammar Alotaibi; Mansour Altuwaijri; Suliman Alshankiti; Mohammed A. Omair; Majid Alsahafi

doi:10.1016/j.jsps.2024.102039

Q1 2024

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis

Saad Alkhowaiter · Maha M. Al Rasheed · Nuha Alammar · Ammar Alotaibi · Mansour Altuwaijri · Suliman Alshankiti · Mohammed A. Omair · Majid Alsahafi

10.1016/j.jsps.2024.102039 386 Views 5 Citations

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Saad, A., Maha, M. A. R., Nuha, A., Ammar, A., Mansour, A., Suliman, A., Mohammed, A. O., Majid, A. (2024). Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102039